VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 132 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $899,000 | -80.3% | 34,400 | -88.5% | 0.18% | -90.6% |
| Q4 2017 | $4,560,000 | +708.5% | 300,000 | +344.4% | 1.91% | +645.3% |
| Q1 2016 | $564,000 | -79.8% | 67,500 | -72.7% | 0.26% | -83.9% |
| Q3 2015 | $2,792,000 | -25.8% | 247,500 | -19.5% | 1.59% | -17.3% |
| Q2 2015 | $3,764,000 | +403.2% | 307,500 | +282.5% | 1.93% | +399.0% |
| Q1 2015 | $748,000 | -76.8% | 80,383 | -64.3% | 0.39% | -67.4% |
| Q4 2014 | $3,222,000 | – | 225,000 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |